The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients

Table 1 Correlation analysis between serglycin (SRGN) and gene markers of immune cells in skin cutaneous melanoma (SKCM) and SKCM-metastasis

Immune cell	Gene marker	SKCM		SKCM-metastasis
Immune cell	Gene marker	Cor	P value	Cor	P value
B cell	CD 19	0.364	< 0.001	0.248	< 0.001
B cell	CD 79	0.331	< 0.001	0.248	< 0.001
CD8⁺ T cell	CD8A	0.538	< 0.001	0.510	< 0.001
CD8⁺ T cell	CD8B	0.499	< 0.001	0466	< 0.001
Neutrophils	CD66b (CEACAM8)	0.006	0.89	0.0110	0.833
	CD11b (ITGAM)	0.592	< 0.001	0.528	< 0.001
	CCR7	0.317	< 0.001	0.267	< 0.001
Dendritic cell	HLA-DPB1	0.515	< 0.001	0.521	< 0.001
	HLA-DQB1	0.458	< 0.001	0.445	< 0.001
	HLA-DRA	0.604	< 0.001	0.603	< 0.001
	HLA-DPA1	0.538	< 0.001	0.519	< 0.001
	BDCA-1(CD1C)	0.287	< 0.001	0.267	< 0.001
	BDCA-4 (NRP1)	0.408	< 0.001	0.326	< 0.001
	CD11c (ITGAX)	0.336	< 0.001	0.281	< 0.001

ISSN: 1471-2407